Zusammenfassung
Klinisches Problem
Symptomatische intrakranielle arterielle Gefäßstenosen sind mit einem hohen Schlaganfallrisiko behaftet. Durch Thrombozytenaggregationshemmer und Antikoagulation kommt es zu keiner wesentlichen Reduktion dieses Risikos. Alternative Methoden sind deshalb dringend erforderlich.
Neue Therapieverfahren
Das Konzept der perkutanen Therapie etwa mit Ballondilatation oder Stentimplantation erscheint auf den ersten Blick erfolgversprechend, weswegen Stents speziell für die Intervention an zerebralen Gefäßen entwickelt wurden.
Leistungsfähigkeit
Die interventionellen Techniken haben sich bereits frühzeitig in nichtrandomisierten Studien bewährt. In der einzigen randomisierten Studie war die Stentimplantation jedoch mit einem hohen perioperativen Risiko verbunden.
Bewertung und Empfehlung für die Praxis
Die bisherige Studienlage lässt bedingt durch Designdefizite keine definitiven Rückschlüsse hinsichtlich der Effektivität der perkutanen Intervention zur Behandlung symptomatischer intrakranieller Stenosen zu. Deshalb wäre es voreilig, diese Therapiemöglichkeit kategorisch abzulehnen.
Abstract
Clinical issue
Symptomatic intracranial stenoses are associated with a high risk of stroke. Medical management with platelet inhibitors or anticoagulation has not been shown to substantially lower this risk. Hence, alternative treatment options are desperately needed.
Treatment innovations
The concept of percutaneous intervention using balloon angioplasty with or without stenting is appealing at first sight which is why intracranial balloons and stents were developed.
Performance
Initial studies using dedicated intracranial stents were more promising; however, the only randomized trial recently published using a dedicated intracranial self-expanding stent demonstrated a high periprocedural complication rate.
Evaluation and practical recommendations
Due to study design limitations it would be premature to categorically denounce an interventional option for the treatment of symptomatic intracranial stenoses. More importantly, the results of the randomized SAMMPRIS trial should stimulate the development of safer technology and patient selection to minimize procedural risks. This will perhaps allow significant risk reduction of this potentially devastating intracranial condition when it cannot otherwise be addressed.
Literatur
Nahab F, Cotsonis G, Lynn M et al (2008) Prevalence and prognosis of coexistent asymptomatic intracranial stenosis. Stroke 39:1039–1041
Qureshi AI, Feldmann E, Gomez CR et al (2009) Intracranial atherosclerotic disease: an update. Ann Neurol 66:730–738
Kasner SE, Chimowitz MI, Lynn MJ et al (2006) Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113:555–563
Kasner SE, Lynn MJ, Chimowitz MI et al (2006) Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 67:1275–1278
(o A) (1985) Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 313:1191–1200
Hatano T, Tsukahara T, Ogino E et al (2005) Stenting for vertebrobasilar artery stenosis. Acta Neurochir Suppl 94:137–141
Levy EI, Horowitz MB, Koebbe CJ et al (2001) Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 48:1215–1221, discussion 21–23
Eberhardt O, Naegele T, Raygrotzki S et al (2006) Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg 43:1145–1154
Marks MP, Marcellus M, Norbash AM et al (1999) Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 30:1065–1069
Marks MP, Marcellus ML, Do HM et al (2005) Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 26:525–530
Marks MP, Wojak JC, Al-Ali F et al (2006) Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 37:1016–1020
Fiorella D, Chow MM, Anderson M et al (2007) A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 61:236–242, discussion 42–43
Chow MM, Masaryk TJ, Woo HH et al (2005) Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: midterm analysis of clinical and radiologic predictors of neurological morbidity and mortality. AJNR Am J Neuroradiol 26:869–874
Engh JA, Levy EI, Howington JU, Guterman LR (2005) Intracranial angioplasty and stenting: modern approaches to revascularization for atherosclerotic disease. Neurosurg Clin N Am 16:297–308, ix
Gomez CR, Misra VK, Campbell MS, Soto RD (2000) Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 21:971–973
Levy EI, Howington JU, Engh JA et al (2005) Submaximal angioplasty and staged stenting for severe posterior circulation intracranial stenosis: a technique in evolution. Neurocrit Care 2:189–197
Yu W, Smith WS, Singh V et al (2005) Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology 64:1055–1057
SSYLVIA Study Investigators (2004) Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35:1388–1392
Bose A, Hartmann M, Henkes H et al (2007) A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 38:1531–1537
Zaidat OO, Klucznik R, Alexander MJ et al (2008) The NIH registry on the use of Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 70:1518–1524
Fiorella D Turk AS, Levy EI, et al (2011) US Wingspan Registry results: 12 months follow-up. Stroke 42:1976–1981
Chimowitz MI, Lynn MJ, Derdeyn CP et al (2011) Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 365:993–1003
Henkes H, Bäzner H, Nelson PK (2011) Comment on: stenting versus aggressive medical therapy for intracranial arterial stenosis. Clin Neuroradiol 21(4):257–259
Vajda Z, Schmid E, Guthe T (2012) The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent. Neurosurgery 70:91–101
Mori T, Fukuoka M, Kazita K, Mori K (1998) Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 19:1525–1533
Kühn AL, Grunwald IQ (2012) SAMMPRIS – a look behind the scenes. Radiologe 52(2):105–106
Interessenkonflikt
Die korrespondierende Autorin gibt für sich und ihren Koautor an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grunwald, I., Bertog, S. Neueste Studien zu intrakraniellen Stenosen. Radiologe 52, 1107–1111 (2012). https://doi.org/10.1007/s00117-012-2371-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-012-2371-7